Semi-Annual Consolidated Statement Of Comprehensive Income

Daito Pharmaceutical Co., Ltd. - Filing #7545245

Concept 2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2021-06-01 to
2022-05-31
2021-06-01 to
2022-05-31
2021-06-01 to
2022-05-31
2021-06-01 to
2022-05-31
2021-06-01 to
2022-05-31
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
3,527,000,000 JPY
3,491,000,000 JPY
3,491,000,000 JPY
3,491,000,000 JPY
3,491,000,000 JPY
4,412,000,000 JPY
4,627,000,000 JPY
4,412,000,000 JPY
4,412,000,000 JPY
4,412,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
281,000,000 JPY
84,000,000 JPY
Foreign currency translation adjustment
21,000,000 JPY
150,000,000 JPY
Remeasurements of defined benefit plans, net of tax
208,000,000 JPY
-41,000,000 JPY
Other comprehensive income
511,000,000 JPY
194,000,000 JPY
Comprehensive income
4,038,000,000 JPY
4,821,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
4,107,000,000 JPY
4,820,000,000 JPY
Comprehensive income attributable to non-controlling interests
-68,000,000 JPY
1,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.